Novo Holdings has co-led an oversubscribed CHF100 million (approximately USD110 million) Series C financing in Numab Therapeutics AG (Numab) alongside HBM Partners, with participation from new investors Forbion via its Forbion Growth Opportunities Fund, Cormorant Asset Management, BVF Partners, RTW Investments, fund and accounts under the management of BlackRock, Octagon
Legend Capital has closed the LC Healthcare Continued Fund I, having raised USD270 million for a secondary transaction that involves healthcare portfolios of two older vintage funds. The fund provides liquidity and helped to enhance returns for existing investors while maximising the value of the fund’s portfolio with new follow-on
EyeSouth Partners (EyeSouth) has completed an affiliation with Retina Care Specialists (RCS), it’s fifth such deal in the state of Florida and twenty-fourth affiliation overall.
Sheridan Capital Partners (Sheridan) has invested in SimiTree Healthcare Consulting (SimiTree), a strategic and equal combination of Simione Healthcare Consultants (Simione) and BlackTree Healthcare Consulting (BlackTree).
Funds affiliated with Lightyear Capital (Lightyear), Oak HC/FT and Greater Sum Ventures (GSV) have completed the sale of Therapy Brands to KKR. Financial terms of the transaction have not been disclosed. Funds affiliated with Lightyear and Oak HC/FT acquired a majority stake in Therapy Brands in July 2018. Therapy Brands
The BIA has today welcomed the Government’s announcement that GBP18 million will be invested in innovative UK life science companies through a relaunched Innovate UK Biomedical Catalyst competition.
Novo Holdings has led an oversubscribed USD125 million Series C financing in Hummingbird Bioscience (Hummingbird), a clinical-stage biotech company focused on developing precision therapies against difficult-to-drug targets to improve treatment outcomes. This is one of the first investments in a privately-held Asian biotech company by Novo Holdings. Novo Holdings recently
Healios – a UK online therapy platform for children and young people with mental health and neurodiverse conditions – has raised GBP7 million in a Series A round led by InHealth Ventures with participation from existing investors AlbionVC. The funding will enable Healios to widen its provision and meet the
Nordic Capital, a private equity investor with a resolute commitment to creating stronger, sustainable businesses, has further invested in ArisGlobal, by acquiring an additional shareholding from the founding Abbhi family. The transaction follows Nordic Capital’s initial investment in ArisGlobal, a provider of innovative software-as-a-service (SaaS) solutions for the life
Arkhn, a specialist in healthcare data interoperability, has finalised a first round of financing of EUR4 million. This financing round was jointly led by Kurma Partners and Newfund, through their respective funds Kurma Diagnostics II and Newfund II, with the support of the European Commission and the public bank Bpifrance.
12 September, 2024 – 6:00 pm
05 June, 2024 – 8:30 am
24 October, 2024 – 8:30 am
14 November, 2024 – 8:00 am
